Back to Results
First PageMeta Content
Pyridines / Benzimidazoles / Organofluorides / Sulfoxides / Takeda Pharmaceutical Company / Pharmaceutical industry / Pioglitazone / Dexlansoprazole / Thiazolidinedione / Chemistry / Organic chemistry / Pharmacology


Takeda Pharmaceutical Company Limited[removed]Consolidated Financial Statements for Fiscal[removed]Results of Operations (1) Analysis of Consolidated Operating results (i) Overview
Add to Reading List

Document Date: 2013-06-18 04:33:09


Open Document

File Size: 274,46 KB

Share Result on Facebook

City

Moscow / Shanghai / /

Company

Takeda Pharmaceutical Company Limited / Amgen / Comércio de Produtos Farmacêuticos Ltda. / Multilab Indústria / Baxter International Inc. / Ajinomoto Pharmaceuticals Co. Ltd. / NPS Pharmaceuticals / Envoy Therapeutics Inc. / Resolve Therapeutics LLC / Pantoprazole / LigoCyte Pharmaceuticals Inc. / Advinus Therapeutics Ltd. / Lundbeck / Nycomed / Norgine BV / Amylin Pharmaceuticals Inc. / URL Pharma Inc. / Sumitomo / AMAG Pharmaceuticals / Emerging / Shonan Incubation Laboratories / BC Cancer Agency of Canada / Inviragen Inc. / Seattle Genetics / Takeda Vaccines (Montana) Inc. / /

Continent

Europe / Asia / North America / /

Country

Netherlands / Norway / Japan / Brazil / Korea / China / India / Denmark / Taiwan / Russia / United States / South Korea / /

Event

FDA Phase / M&A / Name Change / Product Issues / Business Partnership / Product Recall / Reorganization / Company Expansion / Analyst Recommendation / /

Facility

Shonan Research Center / Takeda's Shonan Research Center / /

IndustryTerm

treatment of prostate cancer / treatment of anemia due to chronic kidney disease / treatment of short bowel syndrome / late-stage pipeline products / prescribed anti-hypertensive product / iPS cells technology / hypertension treatment / diabetes treatment / drug discovery utilizing novel technologies / treatment of unresectable advanced or recurrent colorectal cancer / treatment of lupus / treatment of osteoporosis / cancer treatment / treatment of lymphoma / pharmaceutical manufacturing facility / pharmaceutical / treatment of major depressive disorder / research-based pharmaceutical / pharmaceutical market / treatment of hypertension / vitamin-containing products / generic products / treatment of obesity / /

MedicalCondition

CD30 positive anaplastic large cell lymphoma / multiple myeloma / gout / chronic kidney disease / chronic gout / prostate cancer / gastroesophageal reflux disease / breast cancer / multiple myeloma treatment / metastatic adenocarcinoma / cancer / Schizophrenia / Metabolic diseases / advanced non-squamous non-small cell lung cancer / reflux disease / diabetes / endometriosis / non-metastatic osteosarcoma / amyloidosis / serious hypersensitivity / Ulcerative Colitis / systemic anaplastic large cell lymphoma / recurrent colorectal cancer / Parkinson’s disease / short bowel syndrome / osteoporosis / SLE / lymphoma drug ADCETRIS / iron deficiency anaemia / Inflammatory / IBD / Systemic Lupus Erythematosus / major depressive disorder / lymphoma / flu / hyperlipidemia / generic name / refractory multiple myeloma / severely active Crohn’s disease / Alzheimer's dementia / obesity / gastritis / CD30 positive Hodgkin lymphoma / severely active ulcerative colitis / resistant prostate cancer / lupus / influenza / autoimmune diseases / insomnia / iron deficiency / multiple myeloma treatment Increase / peptic ulcer / hypertension / Disease / chronic obstructive pulmonary disease / Crohn’s disease / hyperlipidemia / Hodgkin lymphoma / post-menopausal osteoporosis / mature T-cell lymphoma / pandemic influenza / anemia / acute gout / refractory systemic anaplastic large cell lymphoma / /

MedicalTreatment

concomitant therapy / chemotherapy / /

Organization

American Society of Clinical Oncology / European Commission / European Union / 54th American Society of Hematology / Ministry of Health / R&D / Bank of Japan / Committee for Medicinal Products for Human Use / European Medicines Agency / U.S. Food and Drug Administration / Improvement and Reinforcement of R&D / /

Person

Respiratory / /

Position

General / Envoy / Hb / /

Product

VELCADE / Actoplus met / Amlodipine Besylate / glimepiride / galantamine hydrobromide / Pantoprazole / Vectibix / metronidazole / amoxicillin / Shonan Research Center / prednisone / metformin hydrochloride / Pioglitazone / Uloric / dexamethasone / Rozerem / clarithromycin / ACTOS / risedronate sodium / Lu AA21004 / OMONTYS / Lansoprazole / chlorthalidone / Alinamin tablets / TAK-700 / CD30 / AMG479 / Japan / FDC / ATL-962 / MLN9708 / AA21004 / ADCETRIS / /

Technology

drug discovery / chemotherapy / gene analysis / drug development / iPS cells technology / /

SocialTag